LIVIVO - Search results -

Search results

Result 1 - 10 of total 39

Search options

Article: Clinical hypnotherapy for smoking cessation.

Hempstead, J S

2001 Volume 17, Issue 4, Page(s) 265

MeSH term(s)	Humans ; Hypnosis ; Smoking Cessation/methods
Language	English
Publishing date	2001-12
Publishing country	England
Document type	Journal Article
ZDB-ID	639486-3
ISSN	0266-8130
ISSN	0266-8130
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 3265: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MG 11: Show issues

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints.

Mallidi, Srivalleesha / Mai, Zhiming / Rizvi, Imran / Hempstead, Joshua / Arnason, Stephen / Celli, Jonathan / Hasan, Tayyaba

Journal of biomedical optics

2015 Volume 20, Issue 4, Page(s) 48003

Abstract: In view of the increase in cancer-related mortality rates in low- to middle-income countries (LMIC), there is an urgent need to develop economical therapies that can be utilized at minimal infrastructure institutions. Photodynamic therapy (PDT), a ... ...

Abstract	In view of the increase in cancer-related mortality rates in low- to middle-income countries (LMIC), there is an urgent need to develop economical therapies that can be utilized at minimal infrastructure institutions. Photodynamic therapy (PDT), a photochemistry-based treatment modality, offers such a possibility provided that low-cost light sources and photosensitizers are available. In this proof-of-principle study, we focus on adapting the PDT light source to a low-resource setting and compare an inexpensive, portable, battery-powered light-emitting diode (LED) light source with a standard, high-cost laser source. The comparison studies were performed in vivo in a xenograft murine model of human squamous cell carcinoma subjected to 5-aminolevulinic acid-induced protoporphyrin IX PDT. We observed virtually identical control of the tumor burden by both the LED source and the standard laser source. Further insights into the biological response were evaluated by biomarker analysis of necrosis, microvessel density, and hypoxia [carbonic anhydrase IX (CAIX) expression] among groups of control, LED-PDT, and laser-PDT treated mice. There is no significant difference in the percent necrotic volume and CAIX expression in tumors that were treated with the two different light sources. These encouraging preliminary results merit further investigations in orthotopic animal models of cancers prevalent in LMICs.
MeSH term(s)	Animals ; Biomarkers, Tumor/analysis ; Carbonic Anhydrase IX ; Carbonic Anhydrases/analysis ; Cell Line, Tumor ; Electric Power Supplies ; Equipment Design ; Equipment Failure Analysis ; Female ; Lighting/instrumentation ; Mice ; Mice, Nude ; Neoplasms, Experimental/chemistry ; Neoplasms, Experimental/drug therapy ; Neoplasms, Experimental/pathology ; Photochemotherapy/instrumentation ; Photosensitizing Agents/therapeutic use ; Protoporphyrins/therapeutic use ; Semiconductors ; Treatment Outcome ; Tumor Burden
Chemical Substances	Biomarkers, Tumor ; Photosensitizing Agents ; Protoporphyrins ; protoporphyrin IX (C2K325S808) ; Carbonic Anhydrase IX (EC 4.2.1.1) ; Carbonic Anhydrases (EC 4.2.1.1) ; Car9 protein, mouse (EC 4.2.1.1.)
Language	English
Publishing date	2015-04-14
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	1309154-2
ISSN	1560-2281 ; 1083-3668
ISSN (online)	1560-2281
ISSN	1083-3668
DOI	10.1117/1.JBO.20.4.048003
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4699: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models.

Hempstead, Joshua / Jones, Dustin P / Ziouche, Abdelali / Cramer, Gwendolyn M / Rizvi, Imran / Arnason, Stephen / Hasan, Tayyaba / Celli, Jonathan P

Scientific reports

2015 Volume 5, Page(s) 10093

Abstract: A lack of access to effective cancer therapeutics in resource-limited settings is implicated in global cancer health disparities between developed and developing countries. Photodynamic therapy (PDT) is a light-based treatment modality that has exhibited ...

Abstract	A lack of access to effective cancer therapeutics in resource-limited settings is implicated in global cancer health disparities between developed and developing countries. Photodynamic therapy (PDT) is a light-based treatment modality that has exhibited safety and efficacy in the clinic using wavelengths and irradiances achievable with light-emitting diodes (LEDs) operated on battery power. Here we assess low-cost enabling technology to extend the clinical benefit of PDT to regions with little or no access to electricity or medical infrastructure. We demonstrate the efficacy of a device based on a 635 nm high-output LED powered by three AA disposable alkaline batteries, to achieve strong cytotoxic response in monolayer and 3D cultures of A431 squamous carcinoma cells following photosensitization by administering aminolevulinic acid (ALA) to induce the accumulation of protoporphyrin IX (PpIX). Here we characterize challenges of battery-operated device performance, including battery drain and voltage stability specifically over relevant PDT dose parameters. Further motivated by the well-established capacity of PDT photosensitizers to serve as tumour-selective fluorescence contrast agents, we demonstrate the capability of a consumer smartphone with low-cost add-ons to measure concentration-dependent PpIX fluorescence. This study lays the groundwork for the on-going development of image-guided ALA-PDT treatment technologies for global health applications.
MeSH term(s)	Humans ; Imaging, Three-Dimensional/methods ; Neoplasms/drug therapy ; Neoplasms/pathology ; Photochemotherapy/instrumentation ; Photochemotherapy/methods ; Smartphone
Language	English
Publishing date	2015-05-12
Publishing country	England
Document type	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	2615211-3
ISSN	2045-2322 ; 2045-2322
ISSN (online)	2045-2322
ISSN	2045-2322
DOI	10.1038/srep10093
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

Gilger, Brian C / Stoppini, Riccardo / Wilkie, David A / Clode, Alison B / Pinto, Nelson H / Hempstead, Julie / Gerding, Joseph / Salmon, Jacklyn H

Veterinary ophthalmology

2014 Volume 17 Suppl 1, Page(s) 23–30

Abstract: Purpose: To describe the use of episcleral silicone matrix cyclosporine (ESMC) drug delivery devices in horses with immune-mediated keratitis (IMMK) with evaluation of tolerability and efficacy in long-term control of inflammation.: Methods: ... ...

Abstract	Purpose: To describe the use of episcleral silicone matrix cyclosporine (ESMC) drug delivery devices in horses with immune-mediated keratitis (IMMK) with evaluation of tolerability and efficacy in long-term control of inflammation. Methods: Retrospective study. ESMC implants (1.2 cm length, 30% wt/wt cyclosporine (CsA) in silicone; with approximately 2 μg/day steady-state release for at least 400 days) were used. Results: Nineteen horses (20 eyes) received two or more ESMC implants for superficial stromal (n = 9), midstromal (n = 3), or endothelial (n = 5) IMMK. Three additional horses received two or more ESMC implants for pigmentary keratouveitis (PK). Nine eyes of eight horses with superficial and five eyes of five horses with endothelial IMMK were well controlled after placement of ESMC implants (mean follow-up 176.8 and 207.2 days, respectively). Horses with midstromal IMMK and PK were not controlled with ESMC implants alone, but instead required frequent use of other medications or surgery to control the disease. The mean duration of disease prior to ESMC implantation of horses with midstromal IMMK was 495 ± 203.9 days, compared with 121.6 ± 92.7 days with superficial IMMK. ESMC implants were well tolerated by all horses without documented loss of the device. Conclusions: Results from this preliminary retrospective study suggest that the ESMC implants were well tolerated and associated with treatment success with superficial and endothelial IMMK, especially if placed early in the disease process. Further study is needed to determine the duration of efficacy, number of implants required, and better therapies for chronic midstromal IMMK and pigmentary keratouveitis.
MeSH term(s)	Animals ; Cyclosporine/administration & dosage ; Cyclosporine/therapeutic use ; Drug Implants/administration & dosage ; Female ; Horse Diseases/drug therapy ; Horses ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/therapeutic use ; Keratitis/drug therapy ; Keratitis/veterinary ; Male ; Sclera ; Silicones ; Treatment Outcome
Chemical Substances	Drug Implants ; Immunosuppressive Agents ; Silicones ; Cyclosporine (83HN0GTJ6D)
Language	English
Publishing date	2014-07
Publishing country	England
Document type	Journal Article
ZDB-ID	2011043-1
ISSN	1463-5224 ; 1463-5216
ISSN (online)	1463-5224
ISSN	1463-5216
DOI	10.1111/vop.12087
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Details ▾
- Full text online
- Order with fees

Article: A further consideration in the application of an analysis-of-variance model for the intrasubject replication design.

Kratochwill, T / Alden, K / Demuth, D / Dawson, D / Panicucci, C / Arntson, P / McMurray, N / Hempstead, J / Levin, J

Journal of applied behavior analysis

2006 Volume 7, Issue 4, Page(s) 629–633

Abstract: It is argued that the analysis-of-variance model is inappropriate for assessing treatment effects in single-subject designs. In particular, such designs are demonstrated to violate the crucial assumption concerning the statistical independence of ... ...

Abstract	It is argued that the analysis-of-variance model is inappropriate for assessing treatment effects in single-subject designs. In particular, such designs are demonstrated to violate the crucial assumption concerning the statistical independence of observations. Alternative methods of data analysis are suggested.
Language	English
Publishing date	2006-06-23
Publishing country	United States
Document type	Journal Article
ZDB-ID	218065-0
ISSN	1938-3703 ; 0021-8855
ISSN (online)	1938-3703
ISSN	0021-8855
DOI	10.1901/jaba.1974.7-629
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 1855: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Thymosin beta 10 levels in developing human brain and its regulation by retinoic acid in the HTB-10 neuroblastoma.

Hall, A K / Hempstead, J / Morgan, J I

Brain research. Molecular brain research

1990 Volume 8, Issue 2, Page(s) 129–135

Abstract: Human fetal brain expresses high levels of a polypeptide identified by protein biochemistry and molecular cloning as thymosin beta 10. Within the first 18 months after birth, the thymosin beta 10 content of human brain falls to undetectable levels. In ... ...

Abstract	Human fetal brain expresses high levels of a polypeptide identified by protein biochemistry and molecular cloning as thymosin beta 10. Within the first 18 months after birth, the thymosin beta 10 content of human brain falls to undetectable levels. In order to establish the molecular basis of this process we screened a number of human tumor cell lines derived from the nervous system for the presence of thymosin beta 10. All of the cell line expressed authentic thymosin beta 10. However, in the HTB-10 neuroblastoma, retinoic acid caused a reduction in the level of thymosin beta 10. This effect of the retinoid was conditional upon its continual presence in the tissue culture medium and was not evident in the other cell lines examined. These results suggest that the thymosin beta 10 gene may be a target for retinoids in the developing nervous system.
MeSH term(s)	Amino Acid Sequence ; Base Sequence ; Brain/embryology ; Brain/growth & development ; Brain Chemistry ; Gene Expression Regulation/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Genes ; Humans ; Infant ; Infant, Newborn ; Molecular Sequence Data ; Neoplasm Proteins/biosynthesis ; Nerve Tissue Proteins/biosynthesis ; Nerve Tissue Proteins/genetics ; Neuroblastoma/pathology ; Thymosin/analogs & derivatives ; Thymosin/biosynthesis ; Thymosin/genetics ; Tretinoin/pharmacology ; Tumor Cells, Cultured/drug effects ; Tumor Cells, Cultured/metabolism
Chemical Substances	Neoplasm Proteins ; Nerve Tissue Proteins ; Tretinoin (5688UTC01R) ; Thymosin (61512-21-8) ; thymosin beta(10) (87397-91-9)
Language	English
Publishing date	1990-07
Publishing country	Netherlands
Document type	Journal Article ; Research Support, U.S. Gov't, P.H.S.
ZDB-ID	632883-0
ISSN	1872-6941 ; 0169-328X
ISSN (online)	1872-6941
ISSN	0169-328X
DOI	10.1016/0169-328x(90)90057-k
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2181: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Molecular cloning of a neuron-specific transcript and its regulation during normal and aberrant cerebellar development.

Sangameswaran, L / Hempstead, J / Morgan, J I

Proceedings of the National Academy of Sciences of the United States of America

1989 Volume 86, Issue 14, Page(s) 5651–5655

Abstract: PEP-19 is a brain-specific polypeptide whose levels increase dramatically during the late maturation of the rodent nervous system. By using immunocytochemistry, PEP-19 is shown to be localized to several regions of the central nervous system, notably ... ...

Abstract	PEP-19 is a brain-specific polypeptide whose levels increase dramatically during the late maturation of the rodent nervous system. By using immunocytochemistry, PEP-19 is shown to be localized to several regions of the central nervous system, notably cerebellum, thalamus caudate putamen, and olfactory bulb. We have isolated a 0.5-kilobase cDNA clone that encodes the entire PEP-19 protein sequence, making this one of the smallest primary transcripts and translation products ever identified in eukaryotes. The cDNA was used to investigate the developmental expression of PEP-19 in rodent brain. PEP-19 mRNA rises from low levels at embryonic day 17 of gestation in the rat to a plateau value by day 18 postpartum. This mirrored the levels of the protein determined by radioimmunoassay. Since the rise coincided with the formation of synaptic contacts onto Purkinje cells (a major site of PEP-19 expression), the hypothesis was tested that the activity and/or presence of afferent input modulated PEP-19 expression. Parallel fiber innervation was disrupted either by killing granule cells with the cytostatic agent methylazoxymethanol or by examining PEP-19 levels in cerebellar granuloprival mutant mice (reeler and weaver). The influence of climbing fiber input was assessed by either eliminating them with 3-acetylpyridine or stimulating them with harmaline in both neonatal and mature rats. None of the above altered PEP-19 gene expression in cerebellum, leading us to propose that the signals triggering the PEP-19 gene do not emanate from granule cells or neurons in the olivary nucleus. However, preliminary evidence suggests that PEP-19 is under posttranscriptional regulation.
MeSH term(s)	Aging ; Amino Acid Sequence ; Animals ; Base Sequence ; Blotting, Northern ; Brain/drug effects ; Brain/growth & development ; Brain/metabolism ; Calmodulin-Binding Proteins ; Cerebellar Diseases/chemically induced ; Cerebellar Diseases/metabolism ; Cerebellum/metabolism ; Cloning, Molecular ; Gene Expression Regulation ; Genes ; Harmaline/pharmacology ; Male ; Methylazoxymethanol Acetate/toxicity ; Mice ; Mice, Mutant Strains ; Molecular Sequence Data ; Mutation ; Nerve Tissue Proteins/genetics ; Pyridines/pharmacology ; RNA, Messenger/genetics ; Rats ; Rats, Inbred Strains ; Reference Values ; Transcription, Genetic/drug effects
Chemical Substances	Calmodulin-Binding Proteins ; Nerve Tissue Proteins ; Pcp4 protein, mouse ; Pcp4 protein, rat ; Pyridines ; RNA, Messenger ; 3-acetylpyridine (00QT8FX306) ; Methylazoxymethanol Acetate (592-62-1) ; Harmaline (CN58I4TOET)
Language	English
Publishing date	1989-07
Publishing country	United States
Document type	Journal Article
ZDB-ID	209104-5
ISSN	1091-6490 ; 0027-8424
ISSN (online)	1091-6490
ISSN	0027-8424
DOI	10.1073/pnas.86.14.5651
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1148: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Catecholamines in the vasculature of the rat and rabbit: dopamine, norepinephrine, epinephrine.

Head, R J / Hempstead, J / Berkowitz, B A

Blood vessels

1982 Volume 19, Issue 3, Page(s) 135–147

Abstract: A highly sensitive radioenzymatic assay for the measurement of catecholamines in small blood vessels was applied to the measurement of the levels of norepinephrine (NE), dopamine (DA) and epinephrine (E). The results showed the presence of NE, E and DA ... ...

Abstract	A highly sensitive radioenzymatic assay for the measurement of catecholamines in small blood vessels was applied to the measurement of the levels of norepinephrine (NE), dopamine (DA) and epinephrine (E). The results showed the presence of NE, E and DA in all segments of rat or rabbit vascular tissue analyzed. The predominant catecholamine in the vasculature from both species was NE, and the contents of E and DA were similar for most vessels. Unexpectedly large concentrations of E were associated with rabbit blood vessels.
MeSH term(s)	Animals ; Aorta, Abdominal/analysis ; Catecholamines/analysis ; Dopamine/analysis ; Epinephrine/analysis ; Female ; Male ; Mesenteric Arteries/analysis ; Mesenteric Veins/analysis ; Methyltyrosines/pharmacology ; Muscle, Smooth, Vascular/analysis ; Myocardium/analysis ; Norepinephrine/analysis ; Rabbits ; Rats ; Rats, Inbred Strains ; Vena Cava, Inferior/analysis
Chemical Substances	Catecholamines ; Methyltyrosines ; Dopamine (VTD58H1Z2X) ; Norepinephrine (X4W3ENH1CV) ; Epinephrine (YKH834O4BH)
Language	English
Publishing date	1982
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	125104-1
ISSN	0303-6847 ; 0302-2765
ISSN	0303-6847 ; 0302-2765
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 513: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Monoclonal antibodies to mammalian carnosine synthetase.

Margolis, F L / Grillo, M / Hempstead, J / Morgan, J I

Journal of neurochemistry

1987 Volume 48, Issue 2, Page(s) 593–600

Abstract: A set of mouse monoclonal antibodies has been generated against rabbit muscle carnosine synthetase. The immunoreactivity of these antibodies has been characterized using an immunoassay that permits the separation and direct measurement of the synthetase ... ...

Abstract	A set of mouse monoclonal antibodies has been generated against rabbit muscle carnosine synthetase. The immunoreactivity of these antibodies has been characterized using an immunoassay that permits the separation and direct measurement of the synthetase activity on a second antibody bead complex. Four IgG monoclonal antibodies bind the carnosine synthetase activity from muscle of all mammals tested (mouse, rat, rabbit, cow, dog, and monkey) but not that from chicken muscle. This indicates the mammalian enzymes share epitopes that are absent from the avian enzyme. In addition, relative tissue levels of synthetase activity can be quantified with this immunoassay. Thus, high levels of carnosine synthetase activity are immunoprecipitated from the olfactory tissues of both rat and rabbit. Synthetase activity is generally lower in other tissues (muscle, brain, heart, liver, and gut). Nevertheless, the cross-reactivity of the synthetase from several tissues (olfactory mucosa, muscle, brain, gut, heart, and liver) of a single species indicates the enzyme protein contains similar epitopes in these tissues. Immunoaffinity purification of this low-abundance, unstable enzyme should now be possible for subsequent studies of structure and regulation.
MeSH term(s)	Animals ; Antibodies, Monoclonal ; Cross Reactions ; Immunoglobulin G ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Peptide Synthases/immunology ; Rabbits ; Rats ; Rats, Inbred Strains
Chemical Substances	Antibodies, Monoclonal ; Immunoglobulin G ; Peptide Synthases (EC 6.3.2.-) ; carnosine synthetase (EC 6.3.2.11)
Language	English
Publishing date	1987-02
Publishing country	England
Document type	Journal Article
ZDB-ID	80158-6
ISSN	1471-4159 ; 0022-3042 ; 1474-1644
ISSN (online)	1471-4159
ISSN	0022-3042 ; 1474-1644
DOI	10.1111/j.1471-4159.1987.tb04134.x
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui II Zs.170: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppm.

Aguillard, D P / Albahri, T / Allspach, D / Anisenkov, A / Badgley, K / Baeßler, S / Bailey, I / Bailey, L / Baranov, V A / Barlas-Yucel, E / Barrett, T / Barzi, E / Bedeschi, F / Berz, M / Bhattacharya, M / Binney, H P / Bloom, P / Bono, J / Bottalico, E /

Bowcock, T / Braun, S / Bressler, M / Cantatore, G / Carey, R M / Casey, B C K / Cauz, D / Chakraborty, R / Chapelain, A / Chappa, S / Charity, S / Chen, C / Cheng, M / Chislett, R / Chu, Z / Chupp, T E / Claessens, C / Convery, M E / Corrodi, S / Cotrozzi, L / Crnkovic, J D / Dabagov, S / Debevec, P T / Di Falco, S / Di Sciascio, G / Drendel, B / Driutti, A / Duginov, V N / Eads, M / Edmonds, A / Esquivel, J / Farooq, M / Fatemi, R / Ferrari, C / Fertl, M / Fienberg, A T / Fioretti, A / Flay, D / Foster, S B / Friedsam, H / Froemming, N S / Gabbanini, C / Gaines, I / Galati, M D / Ganguly, S / Garcia, A / George, J / Gibbons, L K / Gioiosa, A / Giovanetti, K L / Girotti, P / Gohn, W / Goodenough, L / Gorringe, T / Grange, J / Grant, S / Gray, F / Haciomeroglu, S / Halewood-Leagas, T / Hampai, D / Han, F / Hempstead, J / Hertzog, D W / Hesketh, G / Hess, E / Hibbert, A / Hodge, Z / Hong, K W / Hong, R / Hu, T / Hu, Y / Iacovacci, M / Incagli, M / Kammel, P / Kargiantoulakis, M / Karuza, M / Kaspar, J / Kawall, D / Kelton, L / Keshavarzi, A / Kessler, D S / Khaw, K S / Khechadoorian, Z / Khomutov, N V / Kiburg, B / Kiburg, M / Kim, O / Kinnaird, N / Kraegeloh, E / Krylov, V A / Kuchinskiy, N A / Labe, K R / LaBounty, J / Lancaster, M / Lee, S / Li, B / Li, D / Li, L / Logashenko, I / Lorente Campos, A / Lu, Z / Lucà, A / Lukicov, G / Lusiani, A / Lyon, A L / MacCoy, B / Madrak, R / Makino, K / Mastroianni, S / Miller, J P / Miozzi, S / Mitra, B / Morgan, J P / Morse, W M / Mott, J / Nath, A / Ng, J K / Nguyen, H / Oksuzian, Y / Omarov, Z / Osofsky, R / Park, S / Pauletta, G / Piacentino, G M / Pilato, R N / Pitts, K T / Plaster, B / Počanić, D / Pohlman, N / Polly, C C / Price, J / Quinn, B / Qureshi, M U H / Ramachandran, S / Ramberg, E / Reimann, R / Roberts, B L / Rubin, D L / Santi, L / Schlesier, C / Schreckenberger, A / Semertzidis, Y K / Shemyakin, D / Sorbara, M / Stöckinger, D / Stapleton, J / Still, D / Stoughton, C / Stratakis, D / Swanson, H E / Sweetmore, G / Sweigart, D A / Syphers, M J / Tarazona, D A / Teubner, T / Tewsley-Booth, A E / Tishchenko, V / Tran, N H / Turner, W / Valetov, E / Vasilkova, D / Venanzoni, G / Volnykh, V P / Walton, T / Weisskopf, A / Welty-Rieger, L / Winter, P / Wu, Y / Yu, B / Yucel, M / Zeng, Y / Zhang, C

Physical review letters

2023 Volume 131, Issue 16, Page(s) 161802

Abstract: We present a new measurement of the positive muon magnetic anomaly, a_{μ}≡(g_{μ}-2)/2, from the Fermilab Muon g-2 Experiment using data collected in 2019 and 2020. We have analyzed more than 4 times the number of positrons from muon decay than in our ... ...

Abstract	We present a new measurement of the positive muon magnetic anomaly, a_{μ}≡(g_{μ}-2)/2, from the Fermilab Muon g-2 Experiment using data collected in 2019 and 2020. We have analyzed more than 4 times the number of positrons from muon decay than in our previous result from 2018 data. The systematic error is reduced by more than a factor of 2 due to better running conditions, a more stable beam, and improved knowledge of the magnetic field weighted by the muon distribution, ω[over ˜]_{p}^{'}, and of the anomalous precession frequency corrected for beam dynamics effects, ω_{a}. From the ratio ω_{a}/ω[over ˜]_{p}^{'}, together with precisely determined external parameters, we determine a_{μ}=116 592 057(25)×10^{-11} (0.21 ppm). Combining this result with our previous result from the 2018 data, we obtain a_{μ}(FNAL)=116 592 055(24)×10^{-11} (0.20 ppm). The new experimental world average is a_{μ}(exp)=116 592 059(22)×10^{-11} (0.19 ppm), which represents a factor of 2 improvement in precision.
Language	English
Publishing date	2023-11-05
Publishing country	United States
Document type	Journal Article
ZDB-ID	208853-8
ISSN	1079-7114 ; 0031-9007
ISSN (online)	1079-7114
ISSN	0031-9007
DOI	10.1103/PhysRevLett.131.161802
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Bonn / Germany

Z 4' 58/153: Show issues

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED